Novorapid Injection (Insulin Aspart) | Fast-Acting Diabetes Treatment
Novorapid Injection (Insulin Aspart) is a fast-acting insulin used to manage post-meal blood sugar spikes in patients with Type 1 and Type 2 diabetes. Begins to act within 10 to 20 minutes of injection, reaches peak effect within 1 to 3 hours, and lasts for 3 to 5 hours, making it ideal for controlling blood sugar rises after meals. Designed to closely mimic the natural insulin response of the body following food intake
Product Overview
NovoRapid Injection is a modern, rapid-acting insulin analogue containing Insulin Aspart. NovoRapid Injection is engineered for the treatment of diabetes mellitus in both adults and children, offering a faster onset and shorter duration of action compared to soluble human insulin. By mimicking the body’s natural prandial (mealtime) insulin release, NovoRapid provides superior control over post-meal blood sugar spikes, allowing for greater flexibility in daily life and dietary habits.
Product Composition
- Insulin Aspart: A rapid-acting insulin analogue produced by recombinant DNA technology, where a single amino acid is replaced to ensure faster absorption.
- Glycerol: Included to maintain the isotonic balance of the solution for comfortable injection.
- Zinc Chloride: Acts as a stabilizing agent to preserve the integrity of the insulin hexamers.
- Phenol and Metacresol: Essential preservatives that maintain the sterility of the injection throughout its use.
Product Specification
| Feature | Specification Details |
| Drug Class | Rapid-Acting Insulin Analogue |
| Active Ingredient | Insulin Aspart (rDNA origin) |
| Concentration | 100 Units/mL (U-100) |
| Onset of Action | 10 to 20 Minutes |
| Peak Effect | 1 to 3 Hours after injection |
| Duration of Action | 3 to 5 Hours |
Mechanism of Action
- Accelerated Monomer Formation: Unlike standard insulin, NovoRapid dissociates into monomers almost instantly upon injection, allowing for immediate entry into the capillary blood.
- Glucose Homeostasis: It binds to insulin receptors on muscle and adipose cells, stimulating the uptake of glucose and inhibiting the liver's production of sugar.
- Metabolic Regulation: It enhances protein synthesis and prevents the breakdown of fats (lipolysis), effectively managing the body's energy storage and utilization.
- Prandial Mimicry: The rapid peak of Insulin Aspart closely matches the timing of carbohydrate absorption from a meal, preventing hyperglycemia.
Key Benefits
- Convenient Mealtime Dosing: Can be taken immediately before a meal, or even shortly after starting to eat, providing lifestyle flexibility.
- Lower Hypoglycemia Risk: Its shorter duration of action means less insulin remains in the system hours after a meal, reducing the risk of nocturnal hypoglycemia.
- Improved HbA1c Control: Enables tighter management of postprandial glucose, which is a critical factor in lowering overall long-term blood sugar levels.
- Pediatric Friendly: A preferred choice for children and adolescents, as it can be administered after meals when food intake is sometimes unpredictable.
- Device Compatibility: Available in multiple formats, including FlexPen, Penfill cartridges, and vials, making it compatible with various delivery preferences.
Usage
NovoRapid Injection is a fast-acting solution that must be administered via subcutaneous injection. It is designed to be taken immediately before a meal (within 5–10 minutes) or, when necessary, shortly after starting a meal. Proper injection site management and adherence to a consistent monitoring schedule are essential for effective glycemic control.
Injection Technique: Administer into the subcutaneous fat of the abdomen, upper arm, or thigh. To ensure consistent absorption and prevent lipohypertrophy (fatty lumps under the skin), always rotate the injection site within the chosen area.
Insulin Pump Use: This formulation is suitable for Continuous Subcutaneous Insulin Infusion (CSII). When used in a pump, it provides both the bolus doses for meals and the continuous basal rate.
Visual Inspection: Before each use, ensure the solution is clear, colorless, and water-like. Do not use the medication if it appears cloudy, tinted, or contains solid particles.
Storage Requirements: Store unopened products in a refrigerator (2°C – 8°C). Once in use, the pen or vial can be kept at room temperature (below 30°C) for up to 4 weeks. Never freeze insulin or expose it to extreme heat.
Mixing Capability: If prescribed, NovoRapid can be mixed with certain intermediate or long-acting insulins (like NPH) in the same syringe, provided the rapid-acting insulin is drawn into the syringe first.
Uses
| Indication | Description of Application |
| Type 1 Diabetes | Acts as the bolus insulin in a basal-bolus regimen to manage carbohydrate intake. |
| Type 2 Diabetes | Prescribed for patients who require mealtime intensification alongside oral medications or basal insulin. |
| Gestational Diabetes | Used to maintain tight blood glucose targets during pregnancy when lifestyle changes are insufficient. |
| Intravenous Therapy | In a hospital setting, it may be administered intravenously under strict medical supervision for acute glycemic stabilization. |
Targeted Therapeutic Applications
Postprandial Spike Control: Specifically engineered to limit the rise in blood sugar levels that occurs 1 to 2 hours after consuming a meal.
Correction Bolus: Used to safely lower blood sugar when readings are unexpectedly high between meals, often referred to as a supplemental dose.
Dynamic Dosing: Allows for "carb counting" where the insulin dose is adjusted precisely based on the amount of carbohydrates about to be consumed.
Pediatric Glycemic Management: Particularly useful for young children whose food intake can be unpredictable, as it allows for post-meal dosing based on actual consumption.
Intensive Insulin Therapy: A core component of intensive regimens aimed at preventing the long-term microvascular complications of diabetes.
Side Effects
Possible Side Effects of Novorapid Injection (Insulin Aspart)
Novorapid Injection may cause side effects in some people. Most are related to blood sugar changes or injection site reactions.
Common Side Effects
- Low blood sugar (hypoglycemia)
- Injection site redness or swelling
- Sweating
- Fatigue
- Mild weight gain
- Headache
Less Common Side Effects
- Dizziness
- Blurred vision
- Itching at injection site
- Skin thickening or thinning at injection site
- Mild swelling in hands or feet
- Nausea
| Rare Side Effects | Details |
|---|---|
| Severe hypoglycemia | Confusion, fainting, or seizures |
| Severe allergic reaction | Rash, swelling, or breathing difficulty |
| Low potassium levels | Muscle weakness or irregular heartbeat |
| Severe vision changes | Temporary worsening of eyesight |
| Serious skin reaction | Severe irritation or widespread rash |
When to Seek Medical Attention
Seek immediate medical help if you experience severe low blood sugar, allergic reactions, breathing difficulty, or major vision changes. Regular blood sugar monitoring helps reduce the risk of complications.
FAQs
Q: What is Novorapid Injection?
A: Novorapid Injection contains Insulin Aspart, a rapid-acting insulin analog used to control blood sugar levels in adults and children with type 1 and type 2 diabetes mellitus. It is designed to closely mimic the natural insulin response of the body following food intake.
Q: What is the product used for?
A: Novorapid is used to control blood sugar levels after meals in people with diabetes mellitus. It is typically used alongside a longer-acting insulin to provide complete blood sugar management throughout the day and night.
Q: How does it work?
A: Insulin Aspart works by allowing glucose from the bloodstream to enter the body's cells where it is used for energy. It acts faster than regular human insulin, helping to prevent the sharp rise in blood sugar that occurs after eating.
Q: How quickly does it work?
A: Novorapid begins to act within 10 to 20 minutes of injection, reaches its peak effect within 1 to 3 hours, and its action lasts for approximately 3 to 5 hours. This rapid onset makes it ideal for controlling post-meal blood sugar spikes.
Q: How is it administered?
A: It is given by subcutaneous injection under the skin of the abdomen, thigh, upper arm, or buttocks. It is available in vials, cartridges, and prefilled FlexPen devices. It can also be used in insulin pumps for continuous subcutaneous insulin infusion.
Q: When should it be injected?
A: Novorapid should be injected immediately before a meal or shortly after starting a meal. It can also be given shortly after a meal if needed. Always follow the doctor's instructions regarding the timing of injections.
Q: What is the correct dose?
A: The dose is individually determined by the doctor based on the patient's blood sugar levels, diet, physical activity, and overall diabetes management plan. Never adjust the dose without consulting your doctor.
Q: Can it be mixed with other insulins?
A: Novorapid can be mixed with certain longer-acting insulins such as NPH insulin when injected subcutaneously. However it should never be mixed with insulin glargine or insulin detemir. Always follow the doctor's instructions regarding mixing of insulins.
Q: Can it be used in an insulin pump?
A: Yes, Novorapid is approved for use in insulin pumps for continuous subcutaneous insulin infusion. The pump tubing and reservoir should be changed regularly as recommended by the doctor or pump manufacturer.
Q: Who should not use it?
A: Patients experiencing hypoglycemia at the time of injection or those with a known allergy to Insulin Aspart or any of its ingredients should not use Novorapid. Always inform your doctor of any allergies before starting treatment.
Q: What are the common side effects?
A: The most common side effect is hypoglycemia, which can cause shakiness, sweating, dizziness, confusion, and rapid heartbeat. Other side effects include injection site reactions such as redness, swelling, or itching, and in some cases lipodystrophy with repeated injections in the same area.
Q: What should I do if hypoglycemia occurs?
A: If you experience symptoms of low blood sugar, consume a fast-acting source of glucose such as fruit juice, glucose tablets, or sugar immediately. Inform your doctor if hypoglycemia occurs frequently so the dose can be reviewed and adjusted.
Interactions
Drug Interactions of Novorapid Injection (Insulin Aspart)
Novorapid Injection contains Insulin Aspart. It may interact with certain medicines and affect blood sugar control, increasing the risk of low or high blood sugar.
| Medicine or Substance | Possible Interaction |
|---|---|
| Oral diabetes medicines | May increase risk of low blood sugar |
| Beta blockers | Can hide warning signs of low blood sugar |
| Alcohol | May increase risk of low blood sugar |
| Corticosteroids | May raise blood sugar levels |
| Diuretics | Can reduce blood sugar control |
| Thyroid medicines | May change insulin requirement |
Important Things to Keep in Mind
- Inform about all medicines before starting insulin
- Monitor blood sugar regularly during treatment
- Watch for signs of low blood sugar such as sweating or dizziness
- Maintain regular meal timing for better control
- Avoid changing medicines without guidance
Health Related Interactions
People with kidney disease, liver problems, or irregular eating habits may experience stronger effects or blood sugar fluctuations. Regular monitoring is important during treatment with Novorapid Injection.
| Manufacturer | : | Novo Nordisk India Pvt Ltd |
| Trade Name | : | NovoLog |
| Generic Search | : | Insulin Aspart |
| Strength | : | 100IU |
Latest Products
